Corrigendum to "GDNF-expressing macrophages restore motor functions at a severe late-stage and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) mice", [J Control Release, 315 (2019) 139-149]
J Control Release. 2022 Mar:343:813-814.
doi: 10.1016/j.jconrel.2022.01.007.
Epub 2022 Jan 25.
1 Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
2 Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
3 Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
4 Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
5 Department of Immunology and Nano-medicine, Florida International University, Herbert Wertheim College of Medicine, Miami, FL 33199, USA.
6 Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: batrakova@unc.edu.